Tech Company Financing Transactions
CranioSense Funding Round
CranioSense, operating out of Bedford, received $5.5 million in funding from The US Department of Defense.
Transaction Overview
Company Name
Announced On
12/17/2025
Transaction Type
Debt
Amount
$5,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Together, these grants fund initiatives that will directly link CranioSense's defense-driven work to its mission of improving brain pressure assessment across all levels of civilian care.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
175 Great Road
Bedford, MA 01730
US
Bedford, MA 01730
US
Phone
Undisclosed
Website
Email Address
Overview
CranioSense is a clinical stage startup on a mission to unlock the hidden parameters of brain health by enabling on demand neurological insight and treatment across the neurological care spectrum. IPASS (Intracranial Pressure Assessment and Screening System) is the first product that we are bringing to the market to realize that mission, a noninvasive medical device for initial diagnosis and continuous monitoring of intracranial hypertension, the point at which ICP becomes clinically unacceptable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Myers
Chief Operating Officer
Kristian DiMatteo
Co-Founder
Gordon Hirschman
Browse more venture capital transactions:
Prev: 12/17/2025: Gambit Cyber venture capital transaction
Next: 12/17/2025: Roamless venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs